(RTTNews) - Moderna Inc. (MRNA) said it raised its lower end of global manufacturing plan for 2021 to 600 million doses of its COVID-19 vaccine from the prior estimation of 500 million doses. It is continuing to invest and add staff to build up to potentially 1 billion doses for 2021.

(RTTNews) - Moderna公司(MRNA)表示，该公司将其2019冠状病毒疫苗的全球生产计划从此前的5亿剂提高到2021年的6亿剂。该公司将继续投资并增加工作人员，到2021年将可能增加到10亿剂疫苗。

The company, which received the emergency use authorization from the U.S. Food and Drug Administration for its vaccine on December 18, said it expects about 100 million doses to be available in the United States by the end of the first quarter of 2021, with 200 million doses total available by the end of the second quarter.

该公司收到紧急使用授权美国食品和药物管理局的疫苗12月18日表示,预计约1亿剂可在美国2021年的第一季度末,2亿年底总剂量可用第二季度。

The company reported that about 18 million doses have been supplied to the U.S. Government to date.

该公司报告说，到目前为止，已经向美国政府提供了大约1800万剂疫苗。

Additional vaccine doses have also been supplied to the Canadian government following authorization by Health Canada's Interim Order on December 23.

在12月23日加拿大卫生部临时命令批准后，还向加拿大政府提供了额外的疫苗剂量。

Moderna said it has partnered with Lonza Ltd. for production inside and outside the United States. Fill-finish services are provided by Catalent Inc. in the U.S., and by ROVI and Recipharm outside the U.S.

Moderna说，该公司已与龙沙有限公司(Lonza Ltd.)合作，在美国国内外进行生产。在美国，Catalent Inc.提供填充物服务，在美国以外，ROVI和Recipharm提供填充物服务

The U.S. Government has agreed to purchase 200 million doses of the Moderna COVID-19 Vaccine with options for potential purchase of 300 million additional doses. The Canadian Government has agreed to purchase 40 million doses.

美国政府已同意购买2亿剂Moderna COVID-19疫苗，并可选择额外购买3亿剂。加拿大政府已经同意购买4000万剂。